protein expression News
-
Find A Way for Rapid Protein Expression with Creative BioMart’s Cell-free Expression System
Creative BioMart Heterologous Protein Expression, a new sub-brand of Creative BioMart, that’s equipped with supportive instruments and a professional technique team, now has developed a cell-free protein expression system to express and reproduce recombinant proteins more efficiently than traditional protein expression techniques. Compared with the traditional intracellular expression ...
-
Creative BioMart Microbe Provides Various Microbial Protein Expression Systems
Creative BioMart Microbe, a sub-brand of Creative BioMart that focuses on microbiological services and products, now provides a variety of microbial protein expression systems, offering customers one-stop services from gene synthesis, vector construction, gene expression to protein purification. The development of DNA recombination technology has brought great changes to protein synthesis. ...
-
Recently Published Apps
We’ve just published OlinkAnalyze DE, a tool that performs differential expression analysis on Olink Normalized Protein eXpression (NPX) data, and OlinkAnalyze QC that generates a quality control and exploratory analysis report on Olink NPX ...
-
Multi-protein Expression Service in Insect Cells Now Available at Profacgen
Profacgen, one of the leading biotechnology companies that provides first-class protein expression services, recently announced the release of multi-protein expression service in insect cells, to help scientists conduct protein co-expression network analysis and interaction studies. Multiprotein complexes are involved in a wide range of cellular processes, including transcription, translation, ...
By Profacgen
-
Revolutionizing Biopharma manufacturing
LenioBio develops efficient and sustainable technologies for protein expression. Company with a clear goal: To simplify protein production and accelerate the delivery of drugs to patients. Revolutionizing Biopharma manufacturing LenioBio develops efficient and sustainable technologies for protein expression. Company with a clear goal: To simplify protein production and accelerate the delivery of ...
-
Corgenix Announces Expansion of Hemorrhagic Fever Virus Product Development Program
Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, has announced an expansion of the collaborative effort for developing test kits for viral hemorrhagic fever (VHF) detection... Joining the collaboration is Vybion, Inc., an Ithaca, N.Y., based biotechnology company. Vybion CEO Lee Henderson, Ph.D., stated, "We are pleased to be ...
By Vybion
-
Thermo Fisher Scientific Unveils Gibco ExpiSf System, First Ever Chemically Defined Insect Protein Expression System
Historically, undefined insect media components such as yeastolate have made it challenging to achieve consistent results and protein yields across multiple experiments. These factors can significantly slow vaccine development at a time when manufacturers are under pressure to develop vaccines faster and more efficiently. Focused on removing barriers to vaccine development and production, Thermo ...
-
LenioBio reaches industrial-scale with its high-yield eukaryotic platform for cell-free protein synthesis.
Dusseldorf, June 8th 2022 – LenioBio GmbH today announced it had achieved a key milestone for the company with the successful linear scaling of its cell-free protein synthesis (CFPS) platform, ALiCE®, to an industrial scale. Through a series of breakthrough developments, ALiCE® can now be used to produce up to 3g/litre of complex, functional proteins in reaction volumes ...
-
Profacgen Launched Antibiotic-free Expression System for Protein Expression Service
Profacgen, a state-of-the-art protein service provider located in the USA that provides custom protein services in biological sciences, recently launched a new and highly effective antibiotic-free expression system to meet scientists’ needs in the protein expression field. Expression vectors inserted with antibiotic resistance genes are mainstream recombinant expression systems that use ...
By Profacgen
-
LenioBio Announces a Scientific Advisory Board Composed of Experts within the Field of Biotechnology
DUSSELDORF, Germany, February 14, 2019 – LenioBio GmbH announces the appointment of Dr. Lorenz M. Mayr, Prof. Govind Rao, and Prof. Stefan Schillberg to LenioBio’s Scientific Advisory Board (SAB). LenioBio is a German life sciences start-up dedicated to the advancement of a transformative technology for the discovery, development, and expression of ‘difficult-to-produce’ ...
-
Profacgen Updated Its E3 Ligase and Target Proteins Development Services
Profacgen has recently updated its E3 Ligase and Target Proteins Development Services, expanding the company’s portfolio of PROTAC development services. The updated services provide scientists with comprehensive advanced platform for their projects. The ubiquitin proteasome system relies heavily on E3 ligases (UPS). As a major modulator of protein homeostasis, UPS is essential in signal ...
By Profacgen
-
Creative Enzymes Announces the Launch of Kex2 Protease from Saccharomyces Cerevisiae, Recombinant
Creative Enzymes, a professional enzyme provider located in New York, USA, is always hammering away at research and trials in order to provide customers with enzyme services and products using its greatest effort. Creative Enzymes recently announced the launch of Kex2 Protease from Saccharomyces cerevisiae, Recombinant, for the cleavage of secreted peptides in yeast exogenous protein expression. ...
-
CD Bioparticles Launches mRNA Transfection Reagents for Research Applications
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, recently introduced a line of highly efficient mRNA Transfection Reagents with low toxicity for research applications, including the mRNA Transfection Reagent, Stem mRNA Transfection Reagent, and mRNA/gRNA Transfection Reagent. mRNA transfection is the process of introducing and expressing mRNA ...
-
A breakthrough in biopharmaceutical protein production; LenioBio announces a new proprietary cell line devoid of plant glycans.
Dusseldorf, May 16, 2022 – the German life science biotech firm, LenioBio GmbH, today announced the generation of a novel plant glycan knockout cell line that will increase the versatility and flexibility of the company’s cell-free protein synthesis (CFPS) system, ALiCE®. LenioBio’s proprietary ALiCE® platform is derived from a tobacco BY-2 plant cell lysate. ...
-
Obsidian Therapeutics Announces Bristol Myers Squibb Opt-In of cytoDRiVE™ Cell Therapy Candidate
Obsidian Therapeutics, Inc., a biotechnology company pioneering controllable cell and gene therapies, today announced that Bristol Myers Squibb (NYSE:BMY) has exercised its option to an exclusive worldwide license to a cell therapy candidate based on Obsidian’s cytoDRiVE™ technology for the controlled expression of the immunomodulatory factor CD40L. This announcement marks the first ...
-
BOC Sciences Celebrates Nobel Prize Awarded to Scientists Behind COVID-19 Vaccines
BOC Sciences expressed its congratulations to Katalin Karikó and Drew Weissman for being recipients of the 2023 Nobel Prize in Physiology or Medicine. The Royal Swedish Academy of Sciences recognized Dr. Karikó and Dr. Weissman's remarkable contributions to science, specifically acknowledging their game-changing discoveries in nucleoside base modifications. BOC Sciences, which ...
By BOC Sciences
-
NanoTemper Technologies and PharmAI launch Proto, a free AI tool to quickly determine which protein labeling strategy works best for molecular interaction measurements
NanoTemper Technologies, in partnership with PharmAI, announced the launch of Proto, a free AI-based web application that reveals the best labeling strategy to help scientists more efficiently measure molecular interactions, a process that’s necessary to discover and develop new drugs. Proto is one the first commercial applications using the AlphaFold protein structure database that was ...
By PharmAI GmbH
-
Innovative SILAC-Based Proteomics Analysis Service Launched by Creative Proteomics
Creative Proteomics, a respected leader in the field of proteomics services, has unveiled its latest offering: the cutting-edge SILAC-Based Proteomics Analysis Service. This advanced service promises to enhance protein dynamics analysis and quantification with a focus on precision and reliability, catering to the research community's evolving needs. SILAC, or Stable Isotope Labeling by Amino ...
-
LenioBio awarded prestigious Eurostars grant
DUSSELDORF, Germany, May 09 2022- LenioBio GmbH announced today that the company has been awarded a 2.75M Euro Eurostars grant to lead a consortiu m comprising one academic and two industrial partners spanning three European countries. Under the project name HiT-GlyP, the consortium comprising LenioBio (Germany), Wageningen University (The Netherlands) and developer of cell-free ...
-
iBio acquires multiple assets of Al drug discovery partner RubrYc
iBio is jockeying for position as a leading player in Al-powered drug discovery while also expanding its immuno-oncology pipeline after closing on the acquisition of multiple assets from its partner, RubrYc Therapeutics. The plant-based drug developer and contract development and manufacturing organization (CDMO) said the deal shores up its ambition to bring immunotherapies to the clinic, ...
By Ibio, Inc.
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you